SCHEMBL4095299

SCHEMBL4095299

Cc1nc(C)c(Cl)c(N)c1Cl

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 1/20 0.40
TLR8 Q9NR97 1/20 0.35
TDP1 Q9NUW8 1/20 0.34
LMNA P02545 3/20 0.33
ALDH1A1 P00352 3/20 0.33
KDM4E B2RXH2 2/20 0.33
NOS1 P29475 2/20 0.32
CHRM4 P08173 4/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
NOS3 P29474 1/20 0.31
NOS2 P35228 1/20 0.31
MEN1 O00255 1/20 0.30
GLA P06280 1/20 0.30
TSHR P16473 1/20 0.30
HTT P42858 1/20 0.30
KMT2A Q03164 1/20 0.30
CHRM2 P08172 1/20 0.30
CHRM1 P11229 1/20 0.30
MAPT P10636 2/20 0.30
GAA P10253 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6904130 0.86 TDP1 (0.45) IDO1TLR8TDP1LMNAALDH1A1
SCHEMBL31042956 0.82 IDO1 (0.34) IDO1TLR8
SCHEMBL2680443 0.76 LMNA (0.36) IDO1TLR8LMNAALDH1A1KDM4E
SCHEMBL11461473 0.75 TLR8 (0.48) IDO1TLR8LMNAALDH1A1KDM4E
SCHEMBL21887822 0.75 TDP1 (0.66) TDP1LMNAALDH1A1KDM4ECHRM4
SCHEMBL11885709 0.75 IDO1 (0.33) IDO1TLR8MEN1KMT2AGAA
SCHEMBL13403366 0.73 IDO1 (0.48) IDO1TLR8LMNAALDH1A1KDM4E
SCHEMBL11717411 0.69 ALDH1A1 (0.40) LMNAALDH1A1KDM4ENOS1L3MBTL1
SCHEMBL11630670 0.69 LMNA (0.41) IDO1TLR8LMNAALDH1A1KDM4E
SCHEMBL23170154 0.69 IDO1 (0.45) IDO1TLR8LMNAALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-57004973-A None JP disclosed
US-20090203692-A1 NOVEL CHEMICAL COMPOUNDS SMITHKLINE BEECHAM CORPORATION 2009-08-13 US disclosed
EP-1885362-A2 NOVEL CHEMICAL COMPOUNDS Smithkline Beecham Corporation (US) 2008-02-13 EP disclosed
WO-2006127458-A2 NOVEL CHEMICAL COMPOUNDS SMITHKLINE BEECHAM CORPORATION (US) 2006-11-30 WO disclosed
JP-S574973-A PREPARATION OF 3,5-DICHLORO-2,6-DIMETHYL-4-PYRIDINOL NIPPON SYNTHETIC CHEM IND CO LTD:THE 1982-01-11 JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090203692-A1 NOVEL CHEMICAL COMPOUNDS HIPK3, HIPK1, HIPK4 IDO1 4436/4885TLR8 4722/4885TDP1 690/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.